Showing 1 - 10 results of 10 for search 'Shidai Jin', query time: 0.04s Refine Results
  1. 1
    Role of STAT3 in Resistance of Non-small Cell Lung Cancer

    Role of STAT3 in Resistance of Non-small Cell Lung Cancer by Sibo SUN, Shidai JIN, Renhua GUO

    Published 2019-07-01
    Get full text
    Article
  2. 2
    miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22

    miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22 by Jun Li, Mingjie Lu, Jiao Jin, Xiyi Lu, Tongpeng Xu, Shidai Jin

    Published 2018-10-01
    Get full text
    Article
  3. 3
    Delivery of platelet TPM3 mRNA into breast cancer cells via microvesicles enhances metastasis

    Delivery of platelet TPM3 mRNA into breast cancer cells via microvesicles enhances metastasis by Bing Yao, Shuang Qu, Ruifeng Hu, Wen Gao, Shidai Jin, Junyi Ju, Quan Zhao

    Published 2019-12-01
    Get full text
    Article
  4. 4
    Concurrent use of anlotinib overcomes acquired resistance to EGFR‐TKI in patients with advanced EGFR‐mutant non‐small cell lung cancer

    Concurrent use of anlotinib overcomes acquired resistance to EGFR‐TKI in patients with advanced EGFR‐mutant non‐small cell lung cancer by Chen Zhang, Honggang Cao, Yanan Cui, Shidai Jin, Wen Gao, Chenjun Huang, Renhua Guo

    Published 2021-10-01
    Get full text
    Article
  5. 5
    A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma

    A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma by Bing Yao, Shuang Qu, Ruifeng Hu, Wen Gao, Shidai Jin, Ming Liu, Quan Zhao

    Published 2019-12-01
    Get full text
    Article
  6. 6
    Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis

    Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis by Jiali Dai, Xinyin Liu, Jun Li, Tianyu Qu, Yanan Cui, Shidai Jin, Erbao Zhang, Renhua Guo

    Published 2023-02-01
    Get full text
    Article
  7. 7
    IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways

    IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways by Xiaomeng Wang, Xiaomeng Wang, Jiali Xu, Jin Chen, Shidai Jin, Jiaqi Yao, Tongfu Yu, Wei Wang, Renhua Guo

    Published 2019-11-01
    Get full text
    Article
  8. 8
    Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting

    Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world settin... by Qianqian Wang, Wen Gao, Fangyan Gao, Shidai Jin, Tianyu Qu, Fan Lin, Chen Zhang, Jingya Zhang, Zhihong Zhang, Liang Chen, Renhua Guo

    Published 2021-05-01
    Get full text
    Article
  9. 9
    Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study

    Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study by Sibo Sun, Yiqian Liu, Ann-Kathrin Eisfeld, Fuxi Zhen, Shidai Jin, Wen Gao, Tongfu Yu, Liang Chen, Wei Wang, Wei Chen, Mingming Yuan, Rongrong Chen, Kai He, Renhua Guo

    Published 2019-06-01
    Get full text
    Article
  10. 10
    Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis

    Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis by Jun Li, Wei Wang, Wei Zhang, Yang W Shao, Lu Shen, Liang Chen, Wen Gao, Jiali Xu, Jiani C Yin, Renhua Guo, Qianghu Wang, Lingxiang Wu, Shidai Jin, Xinyin Liu, Qixing Gong, Chunxiao Sun, Zidun Wang

    Published 2022-11-01
    Get full text
    Article

Search Tools: